PMC:7795856 / 224-332
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7795856","sourcedb":"PMC","sourceid":"7795856","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7795856","text":"C virus (HCV) infections and used as an immune enhancer, which also offers prospects in the context of COVID","tracks":[]}